Aster Capital Management DIFC Ltd Makes New Investment in Cencora, Inc. $COR

Aster Capital Management DIFC Ltd purchased a new position in shares of Cencora, Inc. (NYSE:COR) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 3,721 shares of the company’s stock, valued at approximately $1,257,000. Cencora makes up about 0.6% of Aster Capital Management DIFC Ltd’s investment portfolio, making the stock its 28th largest holding.

A number of other large investors also recently added to or reduced their stakes in the company. L2 Asset Management LLC lifted its stake in Cencora by 51.8% during the fourth quarter. L2 Asset Management LLC now owns 2,287 shares of the company’s stock worth $772,000 after purchasing an additional 780 shares in the last quarter. Islay Capital Management LLC lifted its stake in Cencora by 30.0% during the fourth quarter. Islay Capital Management LLC now owns 7,987 shares of the company’s stock worth $2,698,000 after purchasing an additional 1,845 shares in the last quarter. Cynosure Group LLC acquired a new position in Cencora during the fourth quarter worth $460,000. 71 West Capital Partners acquired a new position in Cencora during the fourth quarter worth $375,000. Finally, Silvant Capital Management LLC lifted its stake in Cencora by 1.6% during the fourth quarter. Silvant Capital Management LLC now owns 33,435 shares of the company’s stock worth $11,293,000 after purchasing an additional 537 shares in the last quarter. 97.52% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of research firms have commented on COR. UBS Group upped their price target on Cencora from $410.00 to $412.00 and gave the stock a “buy” rating in a research note on Thursday, May 7th. Barclays decreased their price target on Cencora from $425.00 to $350.00 and set an “overweight” rating on the stock in a research note on Wednesday, June 10th. Weiss Ratings cut Cencora from a “buy (b)” rating to a “buy (b-)” rating in a research note on Friday, May 22nd. Morgan Stanley set a $342.00 price objective on Cencora in a research report on Friday, May 8th. Finally, Wells Fargo & Company cut their price objective on Cencora from $429.00 to $331.00 and set an “overweight” rating on the stock in a research report on Monday, May 11th. Twelve equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $374.00.

Cencora Stock Down 0.0%

Cencora stock opened at $281.58 on Tuesday. Cencora, Inc. has a twelve month low of $244.82 and a twelve month high of $377.54. The stock’s fifty day simple moving average is $288.36 and its 200-day simple moving average is $326.67. The company has a current ratio of 0.95, a quick ratio of 0.59 and a debt-to-equity ratio of 3.40. The firm has a market capitalization of $54.78 billion, a P/E ratio of 21.59, a P/E/G ratio of 1.52 and a beta of 0.59.

Cencora (NYSE:COR) last posted its earnings results on Wednesday, May 6th. The company reported $4.75 EPS for the quarter, missing the consensus estimate of $4.82 by ($0.07). The business had revenue of $78.36 billion during the quarter, compared to analysts’ expectations of $81.09 billion. Cencora had a net margin of 0.78% and a return on equity of 135.20%. The business’s quarterly revenue was up 3.9% compared to the same quarter last year. During the same period last year, the company earned $4.42 EPS. Cencora has set its FY 2026 guidance at 17.650-17.900 EPS. As a group, equities analysts expect that Cencora, Inc. will post 17.79 earnings per share for the current fiscal year.

Cencora Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Monday, June 1st. Investors of record on Friday, May 15th were issued a $0.60 dividend. This represents a $2.40 annualized dividend and a yield of 0.9%. The ex-dividend date of this dividend was Friday, May 15th. Cencora’s dividend payout ratio is 18.40%.

Cencora declared that its board has approved a stock repurchase plan on Thursday, May 21st that allows the company to repurchase $2.00 billion in outstanding shares. This repurchase authorization allows the company to buy up to 3.9% of its shares through open market purchases. Shares repurchase plans are typically a sign that the company’s board of directors believes its stock is undervalued.

About Cencora

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.